An intravenous infusion containing nicotinamide adenine dinucleotide (NAD+), offered for supplementation purposes.
This treatment involves the administration of NAD+ via intravenous infusion at a dose of 250 mg or 500 mg, provided at the patient’s request. It is intended for supplementation only, and no medical, therapeutic, or wellbeing claims are made.
Administered by qualified clinicians, this infusion does not diagnose, treat, cure, or prevent disease and does not replace medical assessment or treatment.